tiletamine hydrochloride has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachari, K; Bouhenna, MM; Diederich, M; Mameri, N; Orlikova, B; Pinto, DCGA; Schram, B; Silva, AMS; Taibi, N; Talhi, O | 1 |
| Angeloni, C; Fiorentini, D; Hrelia, S; Prata, C; Rizzo, B; Vieceli Dalla Sega, F; Zambonin, L | 1 |
2 other study(ies) available for tiletamine hydrochloride and Leukemia
| Article | Year |
|---|---|
Anti-proliferative, Cytotoxic and NF-ĸB Inhibitory Properties of Spiro(Lactone-Cyclohexanone) Compounds in Human Leukemia.
Topics: Biological Assay; Caspase 3; Caspase 7; Cell Death; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Cyclohexanones; Humans; K562 Cells; Leukemia; NF-kappa B; Spironolactone; Stereoisomerism; Tumor Necrosis Factor-alpha; U937 Cells | 2017 |
Intracellular cysteine oxidation is modulated by aquaporin-8-mediated hydrogen peroxide channeling in leukaemia cells.
Topics: Aquaporins; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cyclohexanones; Cysteine; Humans; Hydrogen Peroxide; Leukemia; NADPH Oxidases; Oxidation-Reduction; PTEN Phosphohydrolase; Reactive Oxygen Species; Signal Transduction; Vascular Endothelial Growth Factor A | 2017 |